Mediterranean Diet, Exercise and Dementia Risk in UK Adults
NCT ID: NCT03673722
Last Updated: 2023-12-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
108 participants
INTERVENTIONAL
2019-04-01
2023-09-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
MedEx-UK is a RCT that will evaluate the feasibility of a multi-domain intervention to increase Mediterranean Dietary Pattern (MDP) adherence and physical activity (PA) in a group of older UK adults who are at above average risk of dementia.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are three intervention arms to the study, and participants will be randomised with minimisation for gender and Mediterranean Diet Adherence Screener score (MEDAS; a validated questionnaire)
1. MDP:
Participants will be asked to alter their consumption of foods consistent with a Mediterranean Diet. Examples include increased intake of fruits and vegetables, nuts, olive oil as the main culinary fat, moderate wine consumption (if they already consume alcohol), preferring white meat over red, and a reduction in commercial sweet and pastries, and sugar-sweetened drinks.
2. MDP plus PA:
As well as the dietary intervention as in 1., participants will be asked to increase their PA using a mixture of structured (e.g. dancing, Zumba classes, swimming etc.) and non-structured (walking up stairs, gardening etc.) activities.
3. Control:
Participants will be given generic healthy eating advice based on the NHS 'Eatwell' plate and UK British Heart Foundation (BHF) guidelines.
The overall purpose of this study is to inform the feasibility and design of a future large-scale UK dementia risk reduction RCT, to observe whether a multi-domain intervention over 2 to 5 years promoting MDP adherence and increased PA can reduce cognitive decline and brain atrophy in adults at above average risk of dementia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MDP only
Participants will be asked to increase their consumption of foods that are consistent with a Mediterranean Dietary Pattern through interaction with the online LEAP2 platform
Foods consistent with a MDP
We aim to increase MDP by 3 points, according to a 14-point MEDAS score
MDP plus PA
Participants will be asked to increase their consumption of foods that are consistent with a Mediterranean Dietary Pattern AND to increase Physical Activity using a mixture of structured and non-structured activities through interaction with the online LEAP2 platform
Foods consistent with a MDP
We aim to increase MDP by 3 points, according to a 14-point MEDAS score
Physical Activity
We aim to increase PA to 150 minutes moderate activity per week.
Control
Participants will be given generic healthy eating advice based on the NHS 'Eatwell' plate and British Heart Foundation (BHF) guidelines
Control
Participants will be given generic healthy eating advice based
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Foods consistent with a MDP
We aim to increase MDP by 3 points, according to a 14-point MEDAS score
Physical Activity
We aim to increase PA to 150 minutes moderate activity per week.
Control
Participants will be given generic healthy eating advice based
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understands and is willing and able to comply with all study procedures, including changes to diet and physical activity levels
* Access to, and able to use, the internet/computer/tablet device
* QRISK3 score of \>=15 (assessed by GP)
* Subjective Memory Complaints (SMC), based on a score of \>16 on the Cognitive Change Index (CCI) (from the first 12 items)
* Stable use of any prescribed medication for at least four weeks
* Normal (or corrected to normal) vision and hearing
* Fluent in written and spoken English
* Willing and able to provide written informed consent
Exclusion Criteria
* Cognition not within normal range, based on a score of \<26 on the Montreal Cognitive Assessment (MoCA); or an indication of cognitive decline, based on a score of ≥2 on Ascertain Dementia (AD-8)
* Evidence of impairment of Instrumental Activities of Daily living (IADLS)
* Moderate to severe depression, assessed by the Patient Health Questionnaire (PHQ-9), a score of \>10 being exclusionary
* Moderate to severe anxiety, assessed by the Generalised Anxiety Disorder Assessment (GAD-7), a score of \>10 being exclusionary
* Current psychotic illness (delusional disorder/schizophrenia)
* History of serious mental illness know to affect cognition (schizophrenia, schizoaffective disorder, bipolar disorder)
* Subjects with other clinically diagnosed psychiatric disorders likely to affect the cognitive measures (as judged by a clinical advisor)
* HIV positive
* Past history or previous MRI evidence of brain damage, significant head trauma (including loss of consciousness as a result), brain surgery, stroke, or serious neurological disorders
* History of alcohol or drug dependency in the last 2 years
* Subjects with existing diagnosed gastrointestinal disorders likely to impact study results (as judged by a clinical advisor)
* History of any major cardiovascular event, such as a myocardial infarction, stroke or TIA
* Diagnosed COPD
* Cancer, or cancer/treatment within the last 12 months
* Diagnosis of type 1 or type 2 diabetes \< 3 months ago
* Clinical diagnosis of liver or kidney disease
* Diagnosed Epilepsy
* Subjects with any other existing medical conditions likely to affect the study measures
* BMI \>40kg/m2
* A habitual Mediterranean Diet Score (MDS) ≥9
* Habitual physical activity of \>60 minutes moderate activity per week, assessed using the International Physical Activity Questionnaire (IPAQ), short form
* Currently actively engaged in a weight loss, other dietary, or physical activity intervention
* Prescribed medications likely to influence the study measures (as judged by a clinical advisor)
* Currently a participant or have participated in any other study involving an investigational product in the last 4 weeks
* Metal implants, e.g. pacemaker that precludes MRI.
* Claustrophobic which precludes MRI scanning.
55 Years
74 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of East Anglia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Marie Minihane, PhD
Role: PRINCIPAL_INVESTIGATOR
University of East Anglia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Birmingham
Birmingham, , United Kingdom
Newcastle University
Newcastle upon Tyne, , United Kingdom
University of East Anglia
Norwich, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jennings A, Shannon OM, Gillings R, Lee V, Elsworthy R, Bundy R, Rao G, Hanson S, Hardeman W, Paddick SM, Siervo M, Aldred S, Mathers JC, Hornberger M, Minihane AM. Effectiveness and feasibility of a theory-informed intervention to improve Mediterranean diet adherence, physical activity and cognition in older adults at risk of dementia: the MedEx-UK randomised controlled trial. BMC Med. 2024 Dec 23;22(1):600. doi: 10.1186/s12916-024-03815-z.
Elsworthy RJ, Jong ST, Hanson S, Shannon OM, Jennings A, Gillings R, Siervo M, Hornberger M, Hardeman W, Mathers JC, Minihane AM, Aldred S. Effects of the COVID-19 associated United Kingdom lockdown on physical activity in older adults at high risk of cardiovascular disease: a mixed methods perspective from the MedEx-UK multicenter trial. Front Public Health. 2024 May 9;12:1371453. doi: 10.3389/fpubh.2024.1371453. eCollection 2024.
Shannon OM, Lee V, Bundy R, Gillings R, Jennings A, Stephan B, Hornberger M, Balanos G, Paddick SM, Hanson S, Hardeman W, Holmes R, Garner N, Aldred S, Siervo M, Mathers JC, Minihane AM. Feasibility and acceptability of a multi-domain intervention to increase Mediterranean diet adherence and physical activity in older UK adults at risk of dementia: protocol for the MedEx-UK randomised controlled trial. BMJ Open. 2021 Feb 5;11(2):e042823. doi: 10.1136/bmjopen-2020-042823.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARUK-PRRF2017-006UK
Identifier Type: -
Identifier Source: org_study_id